technologie-médicale

The "Bellerophon Project" receives EU funding of €5.5 million to develop a vaccine against staphylococcus aureus

A consortium comprising Imaxio, the Jenner Institute (University of Oxford, UK), the European Vaccine Initiative and Preclin Biosystems was selected by the FP7 grant programme. The objective of the project is to bring the development of a vaccine against Staphylococcus aureus to a Phase I clinical trial Read More

Plus

JOIN

THE CIRCLE OF THOSE WHO WANT TO UNDERSTAND OUR TIME OF TRANSITION, LOOK AT THE WORLD WITH OPEN EYES AND ACT

You have received 3 free articles to discover UP'.

Enjoy unlimited access to our content!

From $1.99 per week only.